| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0006-291X(87)80129-8 |
| P8608 | Fatcat ID | release_mlw2e5knvfekpiz2x4s2ootvha |
| P698 | PubMed publication ID | 3632675 |
| P2093 | author name string | Felix CC | |
| Kalyanaraman B | |||
| Korytowski W | |||
| P2860 | cites work | Oxidative ionic metabolites of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): correlation of electroreduction with physiological behavior | Q68856602 |
| Mechanism of oxidation of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+) | Q69014447 | ||
| A catalyst function for MPTP in superoxide formation | Q70103979 | ||
| Formation of superoxide and hydroxyl radicals from 1-methyl-4-phenylpyridinium ion (MPP+): reductive activation by NADPH cytochrome P-450 reductase | Q70136757 | ||
| The regional distribution and cellular localization of iron in the rat brain | Q71334738 | ||
| An electron spin resonance study of the novel radical cation produced during the horseradish peroxidase-catalyzed oxidation of tetramethylhydrazine | Q72935271 | ||
| Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis | Q22242250 | ||
| Pargyline Prevents MPTP-Induced Parkinsonism in Primates | Q28266115 | ||
| Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey | Q28270776 | ||
| Chronic parkinsonism secondary to intravenous injection of meperidine analogues | Q28323857 | ||
| Bioactivation of MPTP: reactive metabolites and possible biochemical sequelae | Q42216518 | ||
| Metabolism of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by liver homogenate fractions | Q42224865 | ||
| The specific vulnerability of the substantia nigra to MPTP is related to the presence of transition metals | Q43466545 | ||
| Interactions of the 1-methyl-4-phenyl-2,3-dihydropyridinium species with synthetic dopamine-melanin | Q43629917 | ||
| Brain Peroxidase and Catalase in Parkinson Disease | Q44295221 | ||
| Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment | Q48386729 | ||
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate | Q48427450 | ||
| Studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). | Q48535155 | ||
| Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects | Q48535241 | ||
| Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP | Q48590320 | ||
| Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors | Q48614146 | ||
| Brain enzyme is the target of drug toxin | Q48621296 | ||
| Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase | Q48681443 | ||
| One-electron reactions in biochemical systems as studied by pulse radiolysis. I. Nicotinamide-adenine dinucleotide and related compounds | Q68583864 | ||
| Chemically induced Parkinson's disease: intermediates in the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to the 1-methyl-4-phenyl-pyridinium ion | Q68820409 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 354-360 | |
| P577 | publication date | 1987-08-01 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Evidence for the one-electron oxidation of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+). | |
| P478 | volume | 147 |
Search more.